Hyperoxaluria Requires TNF Receptors to Initiate Crystal Adhesion and Kidney Stone Disease

Intrarenal crystals trigger inflammation and renal cell necroptosis, processes that involve TNF receptor (TNFR) signaling. Here, we tested the hypothesis that TNFRs also have a direct role in tubular crystal deposition and progression of hyperoxaluria-related CKD. Immunohistochemical analysis reveal...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Society of Nephrology Vol. 28; no. 3; pp. 761 - 768
Main Authors: Mulay, Shrikant R, Eberhard, Jonathan N, Desai, Jyaysi, Marschner, Julian A, Kumar, Santhosh V R, Weidenbusch, Marc, Grigorescu, Melissa, Lech, Maciej, Eltrich, Nuru, Müller, Lisa, Hans, Wolfgang, Hrabě de Angelis, Martin, Vielhauer, Volker, Hoppe, Bernd, Asplin, John, Burzlaff, Nicolai, Herrmann, Martin, Evan, Andrew, Anders, Hans-Joachim
Format: Journal Article
Language:English
Published: United States American Society of Nephrology 01-03-2017
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Intrarenal crystals trigger inflammation and renal cell necroptosis, processes that involve TNF receptor (TNFR) signaling. Here, we tested the hypothesis that TNFRs also have a direct role in tubular crystal deposition and progression of hyperoxaluria-related CKD. Immunohistochemical analysis revealed upregulated tubular expression of TNFR1 and TNFR2 in human and murine kidneys with calcium oxalate (CaOx) nephrocalcinosis-related CKD compared with controls. Western blot and mRNA expression analyses in mice yielded consistent data. When fed an oxalate-rich diet, wild-type mice developed progressive CKD, whereas , and deficient mice did not. Despite identical levels of hyperoxaluria, , and -deficient mice also lacked the intrarenal CaOx deposition and tubular damage observed in wild-type mice. Inhibition of TNFR signaling prevented the induced expression of the crystal adhesion molecules, CD44 and annexin II, in tubular epithelial cells and , and treatment with the small molecule TNFR inhibitor R-7050 partially protected hyperoxaluric mice from nephrocalcinosis and CKD. We conclude that TNFR signaling is essential for CaOx crystal adhesion to the luminal membrane of renal tubules as a fundamental initiating mechanism of oxalate nephropathy. Furthermore, therapeutic blockade of TNFR might delay progressive forms of nephrocalcinosis in oxalate nephropathy, such as primary hyperoxaluria.
AbstractList Intrarenal crystals trigger inflammation and renal cell necroptosis, processes that involve TNF receptor (TNFR) signaling. Here, we tested the hypothesis that TNFRs also have a direct role in tubular crystal deposition and progression of hyperoxaluria-related CKD. Immunohistochemical analysis revealed upregulated tubular expression of TNFR1 and TNFR2 in human and murine kidneys with calcium oxalate (CaOx) nephrocalcinosis-related CKD compared with controls. Western blot and mRNA expression analyses in mice yielded consistent data. When fed an oxalate-rich diet, wild-type mice developed progressive CKD, whereas , and deficient mice did not. Despite identical levels of hyperoxaluria, , and -deficient mice also lacked the intrarenal CaOx deposition and tubular damage observed in wild-type mice. Inhibition of TNFR signaling prevented the induced expression of the crystal adhesion molecules, CD44 and annexin II, in tubular epithelial cells and , and treatment with the small molecule TNFR inhibitor R-7050 partially protected hyperoxaluric mice from nephrocalcinosis and CKD. We conclude that TNFR signaling is essential for CaOx crystal adhesion to the luminal membrane of renal tubules as a fundamental initiating mechanism of oxalate nephropathy. Furthermore, therapeutic blockade of TNFR might delay progressive forms of nephrocalcinosis in oxalate nephropathy, such as primary hyperoxaluria.
Intrarenal crystals trigger inflammation and renal cell necroptosis, processes that involve TNF receptor (TNFR) signaling. Here, we tested the hypothesis that TNFRs also have a direct role in tubular crystal deposition and progression of hyperoxaluria-related CKD. Immunohistochemical analysis revealed upregulated tubular expression of TNFR1 and TNFR2 in human and murine kidneys with calcium oxalate (CaOx) nephrocalcinosis-related CKD compared with controls. Western blot and mRNA expression analyses in mice yielded consistent data. When fed an oxalate-rich diet, wild-type mice developed progressive CKD, whereas Tnfr1-, Tnfr2- , and Tnfr1/2- deficient mice did not. Despite identical levels of hyperoxaluria, Tnfr1-, Tnfr2- , and Tnfr1/2 -deficient mice also lacked the intrarenal CaOx deposition and tubular damage observed in wild-type mice. Inhibition of TNFR signaling prevented the induced expression of the crystal adhesion molecules, CD44 and annexin II, in tubular epithelial cells in vitro and in vivo , and treatment with the small molecule TNFR inhibitor R-7050 partially protected hyperoxaluric mice from nephrocalcinosis and CKD. We conclude that TNFR signaling is essential for CaOx crystal adhesion to the luminal membrane of renal tubules as a fundamental initiating mechanism of oxalate nephropathy. Furthermore, therapeutic blockade of TNFR might delay progressive forms of nephrocalcinosis in oxalate nephropathy, such as primary hyperoxaluria.
Intrarenal crystals trigger inflammation and renal cell necroptosis, processes that involve TNF receptor (TNFR) signaling. Here, we tested the hypothesis that TNFRs also have a direct role in tubular crystal deposition and progression of hyperoxaluria-related CKD. Immunohistochemical analysis revealed upregulated tubular expression of TNFR1 and TNFR2 in human and murine kidneys with calcium oxalate (CaOx) nephrocalcinosis-related CKD compared with controls. Western blot and mRNA expression analyses in mice yielded consistent data. When fed an oxalate-rich diet, wild-type mice developed progressive CKD, whereas Tnfr1-, Tnfr2-, and Tnfr1/2-deficient mice did not. Despite identical levels of hyperoxaluria, Tnfr1-, Tnfr2-, and Tnfr1/2-deficient mice also lacked the intrarenal CaOx deposition and tubular damage observed in wild-type mice. Inhibition of TNFR signaling prevented the induced expression of the crystal adhesion molecules, CD44 and annexin II, in tubular epithelial cells in vitro and in vivo, and treatment with the small molecule TNFR inhibitor R-7050 partially protected hyperoxaluric mice from nephrocalcinosis and CKD. We conclude that TNFR signaling is essential for CaOx crystal adhesion to the luminal membrane of renal tubules as a fundamental initiating mechanism of oxalate nephropathy. Furthermore, therapeutic blockade of TNFR might delay progressive forms of nephrocalcinosis in oxalate nephropathy, such as primary hyperoxaluria.
Author Lech, Maciej
Hans, Wolfgang
Herrmann, Martin
Eltrich, Nuru
Asplin, John
Kumar, Santhosh V R
Grigorescu, Melissa
Hrabě de Angelis, Martin
Eberhard, Jonathan N
Weidenbusch, Marc
Mulay, Shrikant R
Burzlaff, Nicolai
Hoppe, Bernd
Desai, Jyaysi
Marschner, Julian A
Evan, Andrew
Anders, Hans-Joachim
Müller, Lisa
Vielhauer, Volker
Author_xml – sequence: 1
  givenname: Shrikant R
  surname: Mulay
  fullname: Mulay, Shrikant R
  organization: Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
– sequence: 2
  givenname: Jonathan N
  surname: Eberhard
  fullname: Eberhard, Jonathan N
  organization: Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
– sequence: 3
  givenname: Jyaysi
  surname: Desai
  fullname: Desai, Jyaysi
  organization: Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
– sequence: 4
  givenname: Julian A
  surname: Marschner
  fullname: Marschner, Julian A
  organization: Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
– sequence: 5
  givenname: Santhosh V R
  surname: Kumar
  fullname: Kumar, Santhosh V R
  organization: Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
– sequence: 6
  givenname: Marc
  surname: Weidenbusch
  fullname: Weidenbusch, Marc
  organization: Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
– sequence: 7
  givenname: Melissa
  surname: Grigorescu
  fullname: Grigorescu, Melissa
  organization: Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
– sequence: 8
  givenname: Maciej
  surname: Lech
  fullname: Lech, Maciej
  organization: Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
– sequence: 9
  givenname: Nuru
  surname: Eltrich
  fullname: Eltrich, Nuru
  organization: Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
– sequence: 10
  givenname: Lisa
  surname: Müller
  fullname: Müller, Lisa
  organization: Department of Chemistry and Pharmacy and Interdisciplinary Center for Molecular Materials, Inorganic Chemistry and Interdisciplinary Center for Molecular Materials, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
– sequence: 11
  givenname: Wolfgang
  surname: Hans
  fullname: Hans, Wolfgang
  organization: German Mouse Clinic, Institute of Experimental Genetics, Helmholtz-Zentrum München, Neuherberg, Germany
– sequence: 12
  givenname: Martin
  surname: Hrabě de Angelis
  fullname: Hrabě de Angelis, Martin
  organization: German Center for Diabetes Research, Neuherberg, Germany
– sequence: 13
  givenname: Volker
  surname: Vielhauer
  fullname: Vielhauer, Volker
  organization: Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
– sequence: 14
  givenname: Bernd
  surname: Hoppe
  fullname: Hoppe, Bernd
  organization: Department of Pediatrics, University Medical Center, Bonn, Germany
– sequence: 15
  givenname: John
  surname: Asplin
  fullname: Asplin, John
  organization: Litholink Corporation, Laboratory Corporation of America Holdings, Chicago, Illinois
– sequence: 16
  givenname: Nicolai
  surname: Burzlaff
  fullname: Burzlaff, Nicolai
  organization: Department of Chemistry and Pharmacy and Interdisciplinary Center for Molecular Materials, Inorganic Chemistry and Interdisciplinary Center for Molecular Materials, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
– sequence: 17
  givenname: Martin
  surname: Herrmann
  fullname: Herrmann, Martin
  organization: Department for Internal Medicine 3, University Hospital Erlangen, Institute for Clinical Immunology, Erlangen, Germany; and
– sequence: 18
  givenname: Andrew
  surname: Evan
  fullname: Evan, Andrew
  organization: Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, Indiana
– sequence: 19
  givenname: Hans-Joachim
  surname: Anders
  fullname: Anders, Hans-Joachim
  email: hjanders@med.uni-muenchen.de
  organization: Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany; hjanders@med.uni-muenchen.de
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27612997$$D View this record in MEDLINE/PubMed
BookMark eNpVkUlPHDEQhS1ExBauOSIfc-mJl_bSl0ijIRNGQSAFuHCx3O7qYNRjD7Y7yvz79Igl4VRVqlevPukdo_0QAyD0iZIZlZp-sTnMGKGS1KTWcg8dUcF5xWtB9qee1LKSUvFDdJzzIyFUMKUO0CFTkrKmUUfo_mK7gRT_2GFM3uKf8DT6BBnfXi2nwcGmxJRxiXgVfPG2AF6kbS52wPPuAbKPAdvQ4R--C7DFN2Wiw-c-g83wEX3o7ZDh9KWeoLvlt9vFRXV5_X21mF9WrhayVMLJVsm-7YUApru2c04xJhrVsL7nsreu7oRqoCZaNVIRooVrSEsaKqnTrOUn6Ouz72Zs19A5CCXZwWySX9u0NdF6834T_IP5FX8bwZmmsp4MPr8YpPg0Qi5m7bODYbAB4pgN1RMNF5rspLNnqUsx5wT92xtKzC4QM7-5Mv8CmQ7O_od7k78mwP8C0beJXw
CitedBy_id crossref_primary_10_1016_j_ajpath_2020_10_012
crossref_primary_10_1016_j_lfs_2021_119193
crossref_primary_10_3389_fimmu_2018_00619
crossref_primary_10_1007_s00112_019_0668_6
crossref_primary_10_1080_21678707_2019_1571905
crossref_primary_10_1002_jcp_27651
crossref_primary_10_1016_j_fmre_2022_04_020
crossref_primary_10_1002_advs_201903337
crossref_primary_10_1038_s41585_021_00543_4
crossref_primary_10_1159_000533295
crossref_primary_10_1681_ASN_2019020111
crossref_primary_10_1111_jcmm_18235
crossref_primary_10_2215_CJN_11730921
crossref_primary_10_3389_fped_2018_00098
crossref_primary_10_3390_toxins13010050
crossref_primary_10_1016_j_cej_2024_153655
crossref_primary_10_1016_j_ebiom_2019_10_059
crossref_primary_10_3390_ijms23063284
crossref_primary_10_3390_biom14050511
crossref_primary_10_1038_nrneph_2017_10
crossref_primary_10_1080_14728214_2018_1552940
crossref_primary_10_3892_ijmm_2024_5376
crossref_primary_10_1681_ASN_2019080827
crossref_primary_10_1080_15548627_2019_1635382
crossref_primary_10_1038_s41598_020_74198_3
crossref_primary_10_1007_s00345_022_03998_1
crossref_primary_10_1042_CS20230421
crossref_primary_10_1007_s11938_020_00295_x
crossref_primary_10_1016_j_ejphar_2022_175324
crossref_primary_10_1016_j_biopha_2023_114925
crossref_primary_10_1159_000487671
crossref_primary_10_7554_eLife_63642
crossref_primary_10_1038_nrneph_2016_143
crossref_primary_10_1016_j_freeradbiomed_2021_11_010
crossref_primary_10_1007_s00240_019_01155_9
crossref_primary_10_1016_j_jep_2019_112128
crossref_primary_10_1021_acsomega_4c00110
crossref_primary_10_1038_s43246_023_00393_0
crossref_primary_10_1186_s12929_017_0383_3
crossref_primary_10_1093_ndt_gfy239
crossref_primary_10_1016_j_chembiol_2020_03_016
crossref_primary_10_1002_mnfr_202100226
crossref_primary_10_1016_j_redox_2018_03_019
crossref_primary_10_1186_s40816_024_00366_x
crossref_primary_10_14814_phy2_13228
crossref_primary_10_5802_crchim_92
crossref_primary_10_1152_ajprenal_00514_2020
crossref_primary_10_21886_2308_6424_2022_10_3_54_64
crossref_primary_10_3390_ijms22179244
crossref_primary_10_1007_s00775_019_01692_z
crossref_primary_10_1038_s41574_022_00682_7
crossref_primary_10_3389_fimmu_2018_02173
crossref_primary_10_3390_jpm11020074
crossref_primary_10_1080_07391102_2023_2189476
crossref_primary_10_1021_acs_bioconjchem_0c00268
crossref_primary_10_1021_acsptsci_0c00153
crossref_primary_10_3389_fphys_2023_1118342
crossref_primary_10_3390_jpm12101697
crossref_primary_10_1007_s00467_020_04817_8
crossref_primary_10_3389_fimmu_2023_1142207
crossref_primary_10_1093_ndt_gfz080
crossref_primary_10_1042_CS20171574
crossref_primary_10_1111_febs_15174
crossref_primary_10_1111_imr_12551
crossref_primary_10_1016_j_ijbiomac_2023_125275
crossref_primary_10_1016_j_prmcm_2023_100220
Cites_doi 10.1021/ja029575h
10.1038/ki.2013.207
10.1074/jbc.M115.645234
10.1093/ndt/gft248
10.5527/wjn.v3.i4.256
10.1016/j.immuni.2013.12.015
10.1152/ajprenal.00382.2013
10.1155/2013/292953
10.1038/ncomms10274
10.1056/NEJMcp1001011
10.1097/01.mnh.0000232879.50716.6f
10.5527/wjn.v4.i2.235
10.1016/j.neulet.2013.02.051
10.1002/ar.20656
10.1172/JCI63679
10.1073/pnas.0406835101
10.1681/ASN.2013060675
10.1038/nrneph.2012.113
10.1172/JCI17038
10.1097/01.ASN.0000099380.18995.F7
10.1073/pnas.91.15.6987
10.3892/mmr.2015.3744
10.1056/NEJMra1601611
10.1681/ASN.2005040400
10.1056/NEJMra1301564
10.2131/jts.39.875
10.1097/01.ASN.0000038686.17715.42
10.1097/01.ASN.0000046030.24938.0A
ContentType Journal Article
Copyright Copyright © 2017 by the American Society of Nephrology.
Copyright © 2017 by the American Society of Nephrology 2017
Copyright_xml – notice: Copyright © 2017 by the American Society of Nephrology.
– notice: Copyright © 2017 by the American Society of Nephrology 2017
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1681/asn.2016040486
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE

CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1533-3450
EndPage 768
ExternalDocumentID 10_1681_ASN_2016040486
27612997
Genre Journal Article
GrantInformation_xml – fundername: NIDDK NIH HHS
  grantid: U54 DK083908
– fundername: NIDDK NIH HHS
  grantid: P01 DK056788
GroupedDBID ---
.55
.GJ
0R~
18M
29L
2WC
34G
39C
53G
5GY
5RE
5VS
6PF
AAQQT
AAUIN
AAWTL
ABJNI
ABOCM
ACGFO
ACLDA
ADBBV
AENEX
AFEXH
AFFNX
AHOMT
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
ERAAH
F5P
GX1
H13
HYE
HZ~
K-O
KQ8
NPM
O9-
OK1
OVD
P0W
P2P
RHF
RHI
RPM
TEORI
TNP
TR2
W8F
X7M
XVB
YFH
ZGI
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c456t-5c6b76fbf55e28dbdcc72259792ff36fac4d579e40879670085c90b09161c82b3
IEDL.DBID RPM
ISSN 1046-6673
IngestDate Tue Sep 17 21:32:25 EDT 2024
Fri Oct 25 10:51:38 EDT 2024
Thu Nov 21 20:57:20 EST 2024
Wed Oct 16 00:49:53 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Hyperoxaluria
pathology
Chronic inflammation
Kidney stone
Language English
License Copyright © 2017 by the American Society of Nephrology.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c456t-5c6b76fbf55e28dbdcc72259792ff36fac4d579e40879670085c90b09161c82b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
S.R.M. and J.N.E. contributed equally to this work.
OpenAccessLink https://jasn.asnjournals.org/content/jnephrol/28/3/761.full.pdf
PMID 27612997
PQID 1859735804
PQPubID 23479
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5328164
proquest_miscellaneous_1859735804
crossref_primary_10_1681_ASN_2016040486
pubmed_primary_27612997
PublicationCentury 2000
PublicationDate 2017-03-01
PublicationDateYYYYMMDD 2017-03-01
PublicationDate_xml – month: 03
  year: 2017
  text: 2017-03-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of the American Society of Nephrology
PublicationTitleAlternate J Am Soc Nephrol
PublicationYear 2017
Publisher American Society of Nephrology
Publisher_xml – name: American Society of Nephrology
References 28208534 - J Urol. 2017 Mar;197(3 Pt 1):736-737
27665926 - Nat Rev Nephrol. 2016 Nov;12(11):651
Sheng (B11-20231016) 2003; 125
Worcester (B30-20231016) 2013; 305
Wesson (B8-20231016) 2006; 15
Evan (B3-20231016) 2003; 111
Asselman (B7-20231016) 2003; 14
Bhasin (B4-20231016) 2015; 4
Lieske (B10-20231016) 1994; 91
Sheng (B12-20231016) 2005; 16
Sheng (B9-20231016) 2005; 102
Taguchi (B26-20231016) 2014; 25
Mulay (B16-20231016) 2016; 374
Mulay (B20-20231016) 2016; 7
King (B27-20231016) 2013; 542
Neumann (B24-20231016) 2014; 40
Evan (B21-20231016) 2008; 291
Cochat (B15-20231016) 2013; 369
Knauf (B19-20231016) 2013; 84
Hoppe (B2-20231016) 2012; 8
Kumar (B14-20231016) 2003; 14
Worcester (B1-20231016) 2010; 363
Aggarwal (B5-20231016) 2013; 2013
Kiyotake (B25-20231016) 2015; 290
Verhulst (B13-20231016) 2003; 14
Mulay (B23-20231016) 2014; 29
Baumann (B6-20231016) 2014; 3
Ma (B29-20231016) 2015; 12
Mulay (B18-20231016) 2013; 123
Wu (B28-20231016) 2014; 39
References_xml – volume: 125
  start-page: 2854
  year: 2003
  ident: B11-20231016
  article-title: Adhesion between molecules and calcium oxalate crystals: critical interactions in kidney stone formation.
  publication-title: J Am Chem Soc
  doi: 10.1021/ja029575h
  contributor:
    fullname: Sheng
– volume: 84
  start-page: 895
  year: 2013
  ident: B19-20231016
  article-title: NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy.
  publication-title: Kidney Int
  doi: 10.1038/ki.2013.207
  contributor:
    fullname: Knauf
– volume: 290
  start-page: 25322
  year: 2015
  ident: B25-20231016
  article-title: Human Mincle Binds to Cholesterol Crystals and Triggers Innate Immune Responses.
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M115.645234
  contributor:
    fullname: Kiyotake
– volume: 29
  start-page: 507
  year: 2014
  ident: B23-20231016
  article-title: Molecular mechanisms of crystal-related kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease.
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gft248
  contributor:
    fullname: Mulay
– volume: 3
  start-page: 256
  year: 2014
  ident: B6-20231016
  article-title: From crystalluria to kidney stones, some physicochemical aspects of calcium nephrolithiasis.
  publication-title: World J Nephrol
  doi: 10.5527/wjn.v3.i4.256
  contributor:
    fullname: Baumann
– volume: 40
  start-page: 389
  year: 2014
  ident: B24-20231016
  article-title: Clec12a is an inhibitory receptor for uric acid crystals that regulates inflammation in response to cell death.
  publication-title: Immunity
  doi: 10.1016/j.immuni.2013.12.015
  contributor:
    fullname: Neumann
– volume: 305
  start-page: F1574
  year: 2013
  ident: B30-20231016
  article-title: A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I.
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.00382.2013
  contributor:
    fullname: Worcester
– volume: 2013
  start-page: 292953
  year: 2013
  ident: B5-20231016
  article-title: Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators.
  publication-title: BioMed Res Int
  doi: 10.1155/2013/292953
  contributor:
    fullname: Aggarwal
– volume: 7
  start-page: 10274
  year: 2016
  ident: B20-20231016
  article-title: Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis.
  publication-title: Nat Commun
  doi: 10.1038/ncomms10274
  contributor:
    fullname: Mulay
– volume: 363
  start-page: 954
  year: 2010
  ident: B1-20231016
  article-title: Clinical practice. Calcium kidney stones.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMcp1001011
  contributor:
    fullname: Worcester
– volume: 15
  start-page: 386
  year: 2006
  ident: B8-20231016
  article-title: Role of crystal surface adhesion in kidney stone disease.
  publication-title: Curr Opin Nephrol Hypertens
  doi: 10.1097/01.mnh.0000232879.50716.6f
  contributor:
    fullname: Wesson
– volume: 4
  start-page: 235
  year: 2015
  ident: B4-20231016
  article-title: Primary and secondary hyperoxaluria: Understanding the enigma.
  publication-title: World J Nephrol
  doi: 10.5527/wjn.v4.i2.235
  contributor:
    fullname: Bhasin
– volume: 542
  start-page: 92
  year: 2013
  ident: B27-20231016
  article-title: TNF-alpha receptor antagonist, R-7050, improves neurological outcomes following intracerebral hemorrhage in mice.
  publication-title: Neurosci Lett
  doi: 10.1016/j.neulet.2013.02.051
  contributor:
    fullname: King
– volume: 291
  start-page: 325
  year: 2008
  ident: B21-20231016
  article-title: Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
  publication-title: Anat Rec (Hoboken)
  doi: 10.1002/ar.20656
  contributor:
    fullname: Evan
– volume: 123
  start-page: 236
  year: 2013
  ident: B18-20231016
  article-title: Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion.
  publication-title: J Clin Invest
  doi: 10.1172/JCI63679
  contributor:
    fullname: Mulay
– volume: 102
  start-page: 267
  year: 2005
  ident: B9-20231016
  article-title: Adhesion at calcium oxalate crystal surfaces and the effect of urinary constituents.
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0406835101
  contributor:
    fullname: Sheng
– volume: 25
  start-page: 1680
  year: 2014
  ident: B26-20231016
  article-title: Colony-stimulating factor-1 signaling suppresses renal crystal formation.
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2013060675
  contributor:
    fullname: Taguchi
– volume: 8
  start-page: 467
  year: 2012
  ident: B2-20231016
  article-title: An update on primary hyperoxaluria.
  publication-title: Nat Rev Nephrol
  doi: 10.1038/nrneph.2012.113
  contributor:
    fullname: Hoppe
– volume: 111
  start-page: 607
  year: 2003
  ident: B3-20231016
  article-title: Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle.
  publication-title: J Clin Invest
  doi: 10.1172/JCI17038
  contributor:
    fullname: Evan
– volume: 14
  start-page: 3155
  year: 2003
  ident: B7-20231016
  article-title: Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys.
  publication-title: J Am Soc Nephrol
  doi: 10.1097/01.ASN.0000099380.18995.F7
  contributor:
    fullname: Asselman
– volume: 91
  start-page: 6987
  year: 1994
  ident: B10-20231016
  article-title: Renal epithelial cells rapidly bind and internalize calcium oxalate monohydrate crystals.
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.91.15.6987
  contributor:
    fullname: Lieske
– volume: 12
  start-page: 3095
  year: 2015
  ident: B29-20231016
  article-title: Inhibiting tumor necrosis factor-α signaling attenuates postoperative cognitive dysfunction in aged rats.
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2015.3744
  contributor:
    fullname: Ma
– volume: 374
  start-page: 2465
  year: 2016
  ident: B16-20231016
  article-title: Crystallopathies.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1601611
  contributor:
    fullname: Mulay
– volume: 16
  start-page: 1904
  year: 2005
  ident: B12-20231016
  article-title: Crystal surface adhesion explains the pathological activity of calcium oxalate hydrates in kidney stone formation.
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2005040400
  contributor:
    fullname: Sheng
– volume: 369
  start-page: 649
  year: 2013
  ident: B15-20231016
  article-title: Primary hyperoxaluria.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1301564
  contributor:
    fullname: Cochat
– volume: 39
  start-page: 875
  year: 2014
  ident: B28-20231016
  article-title: Role of tumor necrosis factor-α and interleukin-1β in anorexia induction following oral exposure to the trichothecene deoxynivalenol (vomitoxin) in the mouse.
  publication-title: J Toxicol Sci
  doi: 10.2131/jts.39.875
  contributor:
    fullname: Wu
– volume: 14
  start-page: 107
  year: 2003
  ident: B13-20231016
  article-title: Crystal retention capacity of cells in the human nephron: involvement of CD44 and its ligands hyaluronic acid and osteopontin in the transition of a crystal binding- into a nonadherent epithelium.
  publication-title: J Am Soc Nephrol
  doi: 10.1097/01.ASN.0000038686.17715.42
  contributor:
    fullname: Verhulst
– volume: 14
  start-page: 289
  year: 2003
  ident: B14-20231016
  article-title: Annexin II is present on renal epithelial cells and binds calcium oxalate monohydrate crystals.
  publication-title: J Am Soc Nephrol
  doi: 10.1097/01.ASN.0000046030.24938.0A
  contributor:
    fullname: Kumar
SSID ssj0015277
Score 2.5226552
Snippet Intrarenal crystals trigger inflammation and renal cell necroptosis, processes that involve TNF receptor (TNFR) signaling. Here, we tested the hypothesis that...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 761
SubjectTerms Animals
Brief Communications
Crystallization
Humans
Hyperoxaluria - complications
Hyperoxaluria - metabolism
Kidney Calculi - etiology
Mice
Mice, Inbred C57BL
Receptors, Tumor Necrosis Factor, Type I - physiology
Receptors, Tumor Necrosis Factor, Type II - physiology
Title Hyperoxaluria Requires TNF Receptors to Initiate Crystal Adhesion and Kidney Stone Disease
URI https://www.ncbi.nlm.nih.gov/pubmed/27612997
https://search.proquest.com/docview/1859735804
https://pubmed.ncbi.nlm.nih.gov/PMC5328164
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFD64PYgv4t15I4LgUzebpk3yKNMxEYd4AfGlNGmKA-3GLuD-ved07XT65mNpk5YvJ813cr6cA3AWcO1nItGes1J7wqEZmyz0PcmzyBrBhUpov6P7KHsv6uqa0uSE1VmYQrRvTb-Zv3808_5boa0cfthWpRNr3d-1w4ArpPmtGtSQG1Yuehk6CHlRbpFilx7VtCwzNUbKb10-9kjMFaHhCkXFizg68fg_lsuL0h-m-Vsw-WMF6mzAekkd2eX8EzdhxeVbsHpXBse34bU7o6zfn8n7FK2KPTgS-boxe-p18ILkK4PRmE0G7IYEQ8gxWXs0Q3KIXaZvjnbNWJKn7Laf5m7Giizd7Goev9mB5871U7vrlaUTPIuMaOKFNjIyyhD20HGVmtRaiTNXS82zLIiyxIo0lNqJCyU1ndRRodUXBslD5FvFTbAL9Rxfsw9MyQQ5iy99Y7lIZWYEkh6RBA5bR-ieNOC8wi4ezjNkxORZIOAxAh5_A96A0wraGI2YIhNJ7gbTcYykQUsKyIoG7M2hXvRVjVED5NIgLB6gBNnLd9BuikTZpZ0c_LvlIaxxWsYLzdkR1CejqTuG2jidnhRG9wWP8tpw
link.rule.ids 230,315,729,782,786,887,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swED4NJgEvY-PXuo3NSEg8hTaOE9uPqKVqBa0QLRLiJYodR1SCFPWHtP73u0uTssIbj5FjJ8p3jr_zfb4DOA249jORaM9ZqT3h0IxNFvqe5FlkjeBCJbTf0RnI_r1qXVKanLA6C1OI9q0ZnedPz-f56LHQVr4823qlE6vf9JphwBXS_PoGfMb52mhUTnoZPAh5UXCRopceVbUsczVGyq9fDPok54rQdIWi8kUc3Xj8I8v1Zekd13wrmfxvDWrvfvDtv8KXknSyi2XzN_jk8j3Y6pVh9X146CwoX_jf5GmO9shuHcmD3ZQN-228IOHLeDJlszHrktQI2SlrThZIK3HI9NHRfhtL8pRdjdLcLViR35u1lpGfA7hrXw6bHa8suuBZ5FIzL7SRkVGGgIWOq9Sk1kqc81pqnmVBlCVWpKHUTjSU1HTGR4VWNwzSjsi3ipvgEDZzfMx3YEomyHZ86RvLRSozI5AuiSRw2DtCx6YGZ9U3j1-WuTVi8kkQqBiBil-BqsFJBUmM5k8xjSR34_k0RrqhJYVyRQ2OlhCtxqqwrYFcA291A6XWXm9BzIoU2yVGPz7c8w9sd4a96_i627_6CTucyEChXPsFm7PJ3B3DxjSd_y4M9x9Siu_1
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9swED_WDspetu6rS7duGgz25DqWZUt6LElDStdQ1g7GXoz1RQOtE_IBzX-_O8fOmu5tezSWZKzfyfqd7uc7gC8p10kQpY68lToSHs3YhCyJJA-5NYILVdJ5x_BKjn6q_imlydmU-qpF-9aMj6vbu-NqfFNrK6d3Nm51YvHlRS9LuUKaH09diHfgKa7ZLm8d9SaAkPG66CJFMCOqbNnka8xVEp9cjUjSlaP5CkUljDi68vhVlttb019887Fs8sE-NHjxH2-wD88b8slO1k1ewhNfvYK9iya8_hp-DVeUN_y-vF2iXbLvnmTCfs6uRwO8IAHMZDZniwk7I8kRslTWm62QXuKQ7sbTuRsrK8fOx67yK1bn-Wb9dQToDfwYnF73hlFTfCGyyKkWUWZzI_OAwGWeK2ectRLXvpaah5DmobTCZVJ70VVS078-KrO6a5B-5IlV3KRvYbfCx7wDpmSJrCeRibFcOBmMQNokytRj7xwdnA58bee9mK5zbBTkmyBYBYJV_AGrA59bWApcBhTbKCs_Wc4LpB1aUkhXdOBgDdNmrBbfDsgtADcNKMX29h3ErU613eB0-M89P8HeZX9QfDsbnb-HZ5w4QS1g-wC7i9nSH8HO3C0_1rb7G_xr8nU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hyperoxaluria+Requires+TNF+Receptors+to+Initiate+Crystal+Adhesion+and+Kidney+Stone+Disease&rft.jtitle=Journal+of+the+American+Society+of+Nephrology&rft.au=Mulay%2C+Shrikant+R&rft.au=Eberhard%2C+Jonathan+N&rft.au=Desai%2C+Jyaysi&rft.au=Marschner%2C+Julian+A&rft.date=2017-03-01&rft.eissn=1533-3450&rft.volume=28&rft.issue=3&rft.spage=761&rft.epage=768&rft_id=info:doi/10.1681%2FASN.2016040486&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1046-6673&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1046-6673&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1046-6673&client=summon